ARIAGEN INC has a total of 30 patent applications. It increased the IP activity by 366.0%. Its first patent ever was published in 2010. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and macromolecular chemistry and polymers are METABOMED LTD, CAPULUS THERAPEUTICS LLC and UESUGI MOTONARI.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | WIPO (World Intellectual Property Organization) | 5 | |
#4 | Australia | 4 | |
#5 | Taiwan | 2 | |
#6 | Canada | 1 | |
#7 | China | 1 | |
#8 | Israel | 1 | |
#9 | Republic of Korea | 1 | |
#10 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Macromolecular chemistry and polymers | |
#4 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Song Jiasheng | 12 |
#2 | Colabuono Peter | 11 |
#3 | Zhang Suoming | 11 |
#4 | Li Guodong | 11 |
#5 | Johnson Graham | 10 |
#6 | Yang Luqing | 10 |
#7 | Manning David Douglas | 9 |
#8 | Wolf Mark Allan | 8 |
#9 | Yang Luquing | 1 |
#10 | Manning David | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020214740A1 | Chiral indole compounds and their use | |
WO2020106695A1 | Methods of treating cancer | |
WO2020061577A1 | Phosphate derivatives of indole compounds and their use | |
US2019284149A1 | Aryl hydrocarbon receptor modulator | |
EP3713937A2 | Indole compounds as aryl hydrocarbon receptor (ahr) modulators | |
US2019134009A1 | Methods of cancer treatment with 2-(1′H-Indole-3′-carbonyl)-thiazole-4-carboxylic acid methyl ester | |
EP3564239A1 | Aryl hydrocarbon receptor modulator | |
EP3191481A1 | Efficient and scalable systhesis of 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester and its structural analogs | |
EP2496081A1 | Ite for cancer intervention and eradication |